Preston Klassen insider trades

Open-market stock purchases and sales by Preston Klassen, President & Head of R & D at Regulus Therapeutics Inc, from SEC Form 4 filings since Sep 20, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • RGLS Regulus Therapeutics Inc: 1 buy, 1 sale, last Jun 25, 2025
  • MTCR Metacrine, Inc: 1 buy, 3 sales, last Mar 23, 2023
  • ARNA Arena Pharmaceuticals Inc: 3 sales, last Mar 1, 2020
  • CNAT Conatus Pharmaceuticals Inc: other filings, last Jun 27, 2019
  • OREX Orexigen Therapeutics, Inc: 2 sales, last Feb 2, 2016

Get free alerts when Preston Klassen files a new trade →